Publication Name	World Journal of Gastroenterology
Manuscript ID	15202
Country	Italy

Received	2014-11-14 08:38
Peer-Review Started	2014-11-15 16:49
To Make the First Decision	2014-12-26 13:27
Return for Revision	2014-12-29 09:11
Revised	2015-01-02 16:49
Second Decision	2015-03-15 09:25
Accepted by Journal Editor-in-Chief	2015-03-15 15:26
Accepted by Company Editor-in-Chief	2015-03-19 17:22
Articles in Press	2015-03-19 17:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-03 09:07
Publish the Manuscript Online	2015-04-20 15:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Treatment of esophagogastric junction carcinoma: An unsolved debate
Manuscript Source	Invited Manuscript
All Author List	Michele Orditura, Gennaro Galizia, Eva Lieto, Ferdinando De Vita and Fortunato Ciardiello
Funding Agency and Grant Number
Corresponding Author	Michele Orditura, MD, PhD, Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, Second University of Naples, c/o II Policlinico, Edificio 3, Via Pansini, 5, 80131 Naples, Italy. michele.orditura@unina2.it
Key Words	Barrett’s esophagus; Esophagogastric junction adenocarcinoma; Endoscopic resection; Surgery; Chemotherapy; Chemoradiotherapy
Core Tip	Barrett's esophagus (BE) associated with dysplasia is the main risk factor for the development of esophagogastric junction adenocarcinoma (AEG). Currently, screening programs to individuate and eradicate BE represent the best way to reduce AEG cancer. We aim to discuss several endoscopic approaches, surgical strategies for different types of AEG cancer, and multidisciplinary strategies using chemotherapy or chemoradiotherapy may improve the outcome of AGE patients.
Publish Date	2015-04-20 15:10
Citation	Orditura M, Galizia G, Lieto E, De Vita F, Ciardiello F. Treatment of esophagogastric junction carcinoma: An unsolved debate. World J Gastroenterol 2015; 21(15): 4427-4431
URL	http://www.wjgnet.com/1007-9327/full/v21/i15/4427.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i15.4427

Full Article (PDF)	WJG-21-4427.pdf
Full Article (Word)	WJG-21-4427.doc
Manuscript File	15202-Review.doc
Answering Reviewers	15202-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	15202-Conflict-of-interest statement.pdf
Copyright License Agreement	15202-Copyright assignment.pdf
Peer-review Report	15202-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	15202-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	15202-Scientific misconduct check.pdf
Scientific Editor Work List	15202-Scientific editor work list.pdf